The Landscape of Neutralizing Monoclonal Antibodies (nAbs) for Treatment and Prevention of COVID-19.

Autor: de Almeida Oliveira A; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., Praia Borges Freire D; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., Rodrigues de Andrade A; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., de Miranda Marques A; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., da Silva Madeira L; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., Moreno Senna JP; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., Freitas Brasileiro da Silveira IA; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil., de Castro Fialho B; Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Avenida Brasil, 4.365, NAPA, Manguinhos, Rio de Janeiro, RJ 21040‑900 Brazil.

Publikováno v: Journal of pharmaceutical innovation [J Pharm Innov] 2023 Feb 20, pp. 1-19. Date of Electronic Publication: 2023 Feb 20.

Cross-reactivity and immunotherapeutic potential of BamA recombinant protein from Acinetobacter baumannii.

Autor: Vieira de Araujo AE; Bio-Manguinhos, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: anna.vieira@bio.fiocruz.br., Conde LV; Bio-Manguinhos, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: lvcbcn40@gmail.com., da Silva Junior HC; Bio-Manguinhos, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: haroldo.cid@bio.fiocruz.br., de Almeida Machado L; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: biolucasmachado@gmail.com., Lara FA; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: falara@ioc.fiocruz.br., Chapeaurouge A; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: donat.chapeaeurouge@fiocruz.br., Pauer H; National Institute of Science and Technology of Innovation on Diseases of Neglected Populations, Center for Technological Development in Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil. Electronic address: heidipauer@gmail.com., Pires Hardoim CC; São Paulo State University, Institute of Biosciences, Coastal Campus of São Vicente, São Paulo, SP, Brazil. Electronic address: cristianehardoim@gmail.com., Martha Antunes LC; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil; National Institute of Science and Technology of Innovation on Diseases of Neglected Populations, Center for Technological Development in Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil. Electronic address: caetano.antunes@fiocruz.br., D'Alincourt Carvalho-Assef AP; Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: apdca@ioc.fiocruz.br., Moreno Senna JP; Bio-Manguinhos, Oswaldo Cruz Foundation, Brazilian Ministry of Health, Rio de Janeiro, RJ, Brazil. Electronic address: jprocopio@bio.fiocruz.br.

Publikováno v: Microbes and infection [Microbes Infect] 2021 May-Jun; Vol. 23 (4-5), pp. 104801. Date of Electronic Publication: 2021 Feb 11.

Pit-Stop PCR: An Approach to Increase Final Product Yield of Multiplex PCR

Autor: Moreno Senna Jp, Lopes Rf, Chies Jm, José Luiz Rodrigues

Publikováno v: BioTechniques. 26:638-639

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5759154184b629d5c06ea8a4fa0ae10a
https://doi.org/10.2144/99264bm09

16S rRNA amplicon sequencing and antimicrobial resistance profile of intensive care units environment in 41 Brazilian hospitals.

Autor: Carolina de Bastiani, Daniela, Vallone Silva, Claudia, Paula Christoff, Ana, Flores Cruz, Giuliano Netto, Daniel Tavares, Leonardo, Rodrigues de Araújo, Luana Silva, Martins Tomazini, Bruno, Arns, Beatriz, Teixeira Piastrelli, Filipe, Biasi Cavalcanti, Alexandre, Valter de Oliveira, Luiz Felipe, Jose Pereira, Adriano

Publikováno v: Frontiers in Public Health; 2024, p1-13, 13p

Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection.

Autor: Nie, Dan¹ (AUTHOR), Hu, Yue¹ (AUTHOR), Chen, Zhou¹ (AUTHOR), Li, Mingkai¹ (AUTHOR), Hou, Zheng¹ (AUTHOR), Luo, Xiaoxing¹ (AUTHOR), Mao, Xinggang² (AUTHOR), Xue, Xiaoyan¹ (AUTHOR) xxy.0707@163.com

Publikováno v: Journal of Biomedical Science. 1/18/2020, Vol. 27 Issue 1, p1-8. 8p. 1 Diagram.